ÂÜÀòÂÒÂ×

Salma Jutt is a seasoned executive in the MedTech industry, currently serving as the Global Vice President of Strategy and Strategic Capabilities for Ethicon at Johnson & Johnson since February 2022. With extensive experience in commercial leadership, Jutt previously held roles including Vice President of US Sales for Ethicon and Divisional Vice President at Abbott, overseeing significant portfolios in chronic pain therapies and neuromodulation. Prior to that, Jutt occupied executive positions in biotech startups, leading global marketing initiatives for products such as Contrave® and Mysimba®. Jutt's career began at Allergan, where leadership in marketing and sales for renowned aesthetic products was established. Jutt holds an MBA from Pepperdine Graziadio Business School and a Bachelor of Commerce in Marketing from the University of Alberta, complemented by executive education at Northwestern University and leadership training at the Center for Creative Leadership.